Clinical and Regulatory Aspects of Cell Therapy Development

Aug 15, 2014

10 likes | 117 Vues

Clinical and Regulatory Aspects of Cell Therapy Development. Timothy M. Mayleben President and CEO Aastrom Biosciences. Presented by GTC, a conference production company • 626-256-6405• www.gtcbio.com.

Share Presentation

Embed Code

Link

ceo aastrom biosciences
cell therapy development
www gtcbio
timothy m
clinical
conference production

ankti

Télécharger la présentation

Clinical and Regulatory Aspects of Cell Therapy Development

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

Clinical and Regulatory Aspects of Cell Therapy Development Timothy M. Mayleben President and CEO Aastrom Biosciences Presented by GTC, a conference production company • 626-256-6405• www.gtcbio.com

Clinical Aspects of Gout

Recurrent attacks (flares) of an acute inflammatory arthritis with monosodium urate crystals demonstrated in synovial fluid leukocytes ...

1.58k views • 20 slides

pre-clinical and clinical regulatory overview

Outline I. New Drug Review Process: First Principles II. FDA Model of Serial Evaluation:Investigational New Drug (IND) .... Pre-Clinical studies .... Clinical Trials Phases I ? IV New Drug Application (NDA)Post-Marketing Surveillance III. Life Science Reviewers: Roles/Opportunities Pharmacology Physiology Toxicology PathologyMolecular Biology Chemistry Statistical ScienceVeterinary Med9447

533 views • 19 slides

FDA Oversight of Cell Therapy Clinical Trials

FDA Oversight of Cell Therapy Clinical Trials. Celia Witten, Ph.D., M.D. Office Director, Office of Cellular, Tissue, and Gene Therapies CBER/FDA ISSCR/CIRM/ISCT Workshop June 15, 2010 San Francisco, California. FDA Organization . Office of the Commissioner Office of Combination Products

858 views • 29 slides

Clinical Aspects of Tuberculosis

Clinical Aspects of Tuberculosis. Professor Mike McKendrick Lead Physician Department of Infection and Tropical Medicine Royal Hallamshire Hospital Sheffield Honorary Professor Division of Genomic Medicine University of Sheffield. Clinical aspects of TB. Pathogenisis Clinical diagnosis

809 views • 61 slides

Regulatory Aspects of Infection Control

Regulatory Aspects of Infection Control. State and Federal Requirements for Infection Control in Health Care Facilities. Why Regulate Infection Control Practices?. Each year 1.7- 2 million Americans (5-10% of hospitalized patients)acquire at least one infection while hospitalized

585 views • 36 slides

Clinical aspects of HIV

Clinical aspects of HIV. Dr. Amaj Saeed MB.CH.B MSc PhD Clinical virologist amanj.saeed@krg.org. HIV – global impact. 4 th commonest cause of death 34.5 x 10 6 infections worldwide 24.5 x 10 6 in sub-Saharan Africa 33% 15 year olds infected in some African countries

404 views • 23 slides

Clinical Aspects of Buprenorphine Therapy

Clinical Aspects of Buprenorphine Therapy. Opioids and HIV. You may know that… Injection drug use (IDU), either directly or via sexual contact with an IDU partner, accounts for one-third of the cumulative estimated AIDS cases in the U.S. Opioids : Shocking Facts.

743 views • 53 slides

Clinical Aspects of HIV

Clinical Aspects of HIV. Rachel Gallen , Eduardo Cortez-Garcia, Kelli Chaviano , Amber Childers, James Barr April 5, 2012. Objectives. Discuss diagnosis of HIV Discuss screening infected individuals for other chronic infections

959 views • 50 slides

Clinical Aspects of the Cell Cycle

Clinical Aspects of the Cell Cycle. Clinical aspects of Mitosis. Crossing over does NOT occur in somatic cells (as homologous chromosomes do not usually pair in mitosis). If it occurs (somatic crossing over) it produces cancer. Apoptosis.

275 views • 14 slides

Policy and regulatory aspects

Switchover from Analogue to Digital Terrestrial Television Broadcasting in Central and Eastern Europe Case study of Serbia Péter Vári Belgrade, 28th April 2009. Policy and regulatory aspects.

349 views • 19 slides

REGULATORY ASPECTS OF NPP SAFETY

REGULATORY ASPECTS OF NPP SAFETY. International Conference on Strengthening of Nuclear Safety in Eastern Europe Vienna, June 1999. Ján Š t u l l e r, Petr B r a n d e j s, Alexander M i a s n i k o v, Miroslav Š v á b State Office for Nuclear Safety Czech Republic.

639 views • 42 slides

Clinical Aspects of Antimicrobial Therapy

Clinical Aspects of Antimicrobial Therapy. CONTENTS OF LECTURE. Empiric Antibiotic Guidelines Antibiotic Policy, Audit, Surveillance Summary of commonly used antibiotics For this session a copy of the Empiric Antibiotics guidelines for SJH should be used by each student for clinical scenarios.

668 views • 51 slides

Policy and regulatory aspects

Switchover from Analogue to Digital Terrestrial Television Broadcasting in Central and Eastern Europe Case study of Germany (based on MABB reports) Péter Vári Belgrade, 28th April 2009. Policy and regulatory aspects. The German planned multiphase switchover, generally by states.

304 views • 20 slides

Clinical Aspects of Hypertension

Clinical Aspects of Hypertension. Anna Maio, M.D. Incidence and Prevalence. 58-65 million Americans 30% incidence in the 18 and older age group 1/2 of people over 65 are hypertensive 15% of whites and 25% of African Americans--reason unknown

403 views • 28 slides

Legal and Regulatory Aspects

Legal and Regulatory Aspects. ICAI Indore Dt.24.01.2014. Contents. Banking Law & Practice Banking Regulation Act Banking Laws (Amendment) Act, 2012 Types of charges over securities ( Transfer of Property Act, Indian Contract Act, SARFAESI)

1.25k views • 82 slides

Institutional and regulatory aspects

URUGUAY Sustainability of the National Communication process CGE Workshop on Exchange of Experiences and Good Practices among NAI Parties in Preparing National Communications and on Cross-Cutting Issues, Cairo, Egypt. 20-22 September 2007. Institutional and regulatory aspects.

320 views • 14 slides

RMP: DEFINITIONS AND REGULATORY ASPECTS

RMP: DEFINITIONS AND REGULATORY ASPECTS. Marc Czarka, MD, FBCPM Managing Partner HM3A ( Market Autorisation and Access Associates ). IS IT A NEW ITCH?. Nature 296, 387 - 390 ( 01 April 1982 ); doi:10.1038/296387a0

332 views • 22 slides

REGULATORY ASPECTS ON

REGULATORY ASPECTS ON CONFORMITY ASSESSMENT AND HOMOLOGATION FOR TELECOMMUNICATION PRODUCTS ANATEL - BRAZIL Julio Cesar Fonseca Technical Regulations Manager ITU Consultation on conformance Assessment and Interoperability Testing – Quito - Ecuador, 6 July 2010.

477 views • 36 slides

Legal and Regulatory Aspects

Legal and Regulatory Aspects. Contents. Banking Law & Practice Banking Regulation Act Banking Laws (Amendment) Act, 2012 Types of charges over securities ( Transfer of Property Act, Indian Contract Act, SARFAESI) Credit Information Companies (Regulation) Act, 2005

1.07k views • 82 slides

Regulatory Aspects of Pharmaceutical Excipients

Regulatory Aspects of Pharmaceutical Excipients. PQRI Workshop Nick Buhay Acting Director Division of Manufacturing and Product Quality Office of Compliance Center for Drug Evaluation and Research Food and Drug Administration Marriott Hotel and Convention Center October 10, 2006.

248 views • 11 slides

Policy and regulatory aspects

Switchover from Analogue to Digital Terrestrial Television Broadcasting in Central and Eastern Europe Case Study of Poland Péter Vári Belgrade, 28th April 2009. Policy and regulatory aspects.

279 views • 20 slides

Regulatory Aspects of Clinical Trials in Malaysia

Regulatory Aspects of Clinical Trials in Malaysia. Centre for Investigational New Product National Pharmaceutical Control Bureau, MOH. OUTLINE. Introduction Guidelines and Legal Requirements Application Process Audit and Inspection. *Note

786 views • 62 slides

More Related